{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:58:10Z","timestamp":1773518290547,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:00:00Z","timestamp":1456704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:00:00Z","timestamp":1456704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R03-CA169888"],"award-info":[{"award-number":["R03-CA169888"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01-CA058420"],"award-info":[{"award-number":["R01-CA058420"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UMI-CA164974"],"award-info":[{"award-number":["UMI-CA164974"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10552-016-0728-3","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T11:07:25Z","timestamp":1456744045000},"page":"545-552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["History of uterine leiomyoma and risk of endometrial cancer in black women"],"prefix":"10.1007","volume":"27","author":[{"given":"Lauren A.","family":"Wise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd R.","family":"Sponholtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucile L.","family":"Adams-Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Kuohung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"LaValley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie R.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,29]]},"reference":[{"key":"728_CR1","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1158\/1055-9965.EPI-15-0316","volume":"24","author":"ML Cote","year":"2015","unstructured":"Cote ML, Ruterbusch JJ, Olson SH, Lu K, Ali-Fehmi R (2015) The growing burden of endometrial cancer: a major racial disparity affecting black women. Cancer Epidemiol Biomarkers Prev 24:1407\u20131415","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"728_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1158\/1055-9965.EPI-12-0996","volume":"22","author":"PM Jamison","year":"2013","unstructured":"Jamison PM, Noone AM, Ries LA, Lee NC, Edwards BK (2013) Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol Biomarkers Prev 22:233\u2013241","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"728_CR3","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/jnci\/dji378","volume":"97","author":"ME Sherman","year":"2005","unstructured":"Sherman ME, Carreon JD, Lacey JV Jr, Devesa SS (2005) Impact of hysterectomy on endometrial carcinoma rates in the United States. J Natl Cancer Inst 97:1700\u20131702","journal-title":"J Natl Cancer Inst"},{"key":"728_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1158\/1055-9965.EPI-12-0991","volume":"22","author":"RL Siegel","year":"2013","unstructured":"Siegel RL, Devesa SS, Cokkinides V, Ma J, Jemal A (2013) State-level uterine corpus cancer incidence rates corrected for hysterectomy prevalence, 2004 to 2008. Cancer Epidemiol Biomarkers Prev 22:25\u201331","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"728_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.annepidem.2014.07.018","volume":"24","author":"A Stang","year":"2014","unstructured":"Stang A, Hawk H, Knowlton R, Gershman ST, Kuss O (2014) Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010. Ann Epidemiol 24:849\u2013854","journal-title":"Ann Epidemiol"},{"key":"728_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100\u2013107","journal-title":"Am J Obstet Gynecol"},{"key":"728_CR7","first-page":"CR24","volume":"14","author":"RM Merrill","year":"2008","unstructured":"Merrill RM (2008) Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit 14:CR24\u2013CR31","journal-title":"Med Sci Monit"},{"issue":"541","key":"728_CR8","first-page":"e1","volume":"202","author":"MK Whiteman","year":"2010","unstructured":"Whiteman MK, Kuklina E, Jamieson DJ, Hillis SD, Marchbanks PA (2010) Inpatient hospitalization for gynecologic disorders in the United States. Am J Obstet Gynecol 202(541):e1\u2013e6","journal-title":"Am J Obstet Gynecol"},{"key":"728_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0029-7844(97)00534-6","volume":"90","author":"LM Marshall","year":"1997","unstructured":"Marshall LM, Spiegelman D, Barbieri RL et al (1997) Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90:967\u2013973","journal-title":"Obstet Gynecol"},{"key":"728_CR10","first-page":"180","volume":"21","author":"PG Anastasiadis","year":"2000","unstructured":"Anastasiadis PG, Koutlaki NG, Skaphida PG, Galazios GC, Tsikouras PN, Liberis VA (2000) Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol 21:180\u2013183","journal-title":"Eur J Gynaecol Oncol"},{"key":"728_CR11","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/0026-0495(94)90118-X","volume":"43","author":"R Pasquali","year":"1994","unstructured":"Pasquali R, Casimirri F, Venturoli S et al (1994) Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome. Metabolism 43:706\u2013713","journal-title":"Metabolism"},{"key":"728_CR12","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1067\/mob.2003.247","volume":"188","author":"L Savelli","year":"2003","unstructured":"Savelli L, De Iaco P, Santini D et al (2003) Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol 188:927\u2013931","journal-title":"Am J Obstet Gynecol"},{"key":"728_CR13","first-page":"120","volume":"3","author":"EG Silva","year":"1990","unstructured":"Silva EG, Jenkins R (1990) Serous carcinoma in endometrial polyps. Mod Pathol 3:120\u2013128","journal-title":"Mod Pathol"},{"key":"728_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000010172","volume":"48","author":"S Takamizawa","year":"1999","unstructured":"Takamizawa S, Minakami H, Usui R et al (1999) Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas. Gynecol Obstet Invest 48:193\u2013196","journal-title":"Gynecol Obstet Invest"},{"key":"728_CR15","first-page":"414","volume":"83","author":"WH Parker","year":"1994","unstructured":"Parker WH, Fu YS, Berek JS (1994) Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83:414\u2013418","journal-title":"Obstet Gynecol"},{"key":"728_CR16","first-page":"124","volume":"77","author":"LG Escobedo","year":"1991","unstructured":"Escobedo LG, Lee NC, Peterson HB, Wingo PA (1991) Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol 77:124\u2013128","journal-title":"Obstet Gynecol"},{"key":"728_CR17","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1158\/1055-9965.EPI-08-0936","volume":"18","author":"J Fortuny","year":"2009","unstructured":"Fortuny J, Sima C, Bayuga S et al (2009) Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev 18:1448\u20131456","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"728_CR18","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1158\/1055-9965.EPI-05-0394","volume":"14","author":"LA Brinton","year":"2005","unstructured":"Brinton LA, Sakoda LC, Sherman ME et al (2005) Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev 14:2929\u20132935","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"728_CR19","first-page":"1336","volume":"97","author":"ER Becker","year":"2005","unstructured":"Becker ER, Spalding J, DuChane J, Horowitz IR (2005) Inpatient surgical treatment patterns for patients with uterine fibroids in the United States, 1998\u20132002. J Natl Med Assoc 97:1336\u20131342","journal-title":"J Natl Med Assoc"},{"key":"728_CR20","first-page":"1","volume":"154","author":"M Viswanathan","year":"2007","unstructured":"Viswanathan M, Hartmann K, McKoy N, Stuart G, Rankins N, Thieda P, Lux LJ, Lohr KN (2007) Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess (Full Rep) 154:1\u2013122","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"728_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1055\/s-2007-1018888","volume":"10","author":"MS Rein","year":"1992","unstructured":"Rein MS, Nowak RA (1992) Biology of uterine myomas and myometrium in vitro. Seminar Reprod Endocrinol 10:310\u2013319","journal-title":"Seminar Reprod Endocrinol"},{"key":"728_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1289\/ehp.00108s5791","volume":"108","author":"MS Rein","year":"2000","unstructured":"Rein MS (2000) Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect 108:791\u2013793","journal-title":"Environ Health Perspect"},{"key":"728_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9378(95)90077-2","volume":"172","author":"MS Rein","year":"1995","unstructured":"Rein MS, Barbieri RL, Friedman AJ (1995) Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 172:14\u201318","journal-title":"Am J Obstet Gynecol"},{"key":"728_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1055\/s-2007-1016336","volume":"14","author":"J Andersen","year":"1996","unstructured":"Andersen J (1996) Growth factors and cytokines in uterine leiomyomas. Seminar Reprod Endocrinol 14:269\u2013282","journal-title":"Seminar Reprod Endocrinol"},{"key":"728_CR25","first-page":"225","volume":"12","author":"J Andersen","year":"1998","unstructured":"Andersen J (1998) Factors in fibroid growth. Baillieres Clin Obstet Gynaecol 12:225\u2013243","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"728_CR26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45789-4","volume":"36","author":"VC Buttram","year":"1981","unstructured":"Buttram VC, Reiter RC (1981) Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36:433\u2013445","journal-title":"Fertil Steril"},{"key":"728_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1210\/mend-4-3-510","volume":"4","author":"YM Huet-Hudson","year":"1990","unstructured":"Huet-Hudson YM, Chakraborty C, Suzaki Y, Andrews GK, Dey SK (1990) Estrogen regulates synthesis of epidermal growth factor in mouse uterine epithelial cells. Mol Endocrinol 4:510\u2013523","journal-title":"Mol Endocrinol"},{"key":"728_CR28","first-page":"658","volume":"74","author":"P Tommola","year":"1989","unstructured":"Tommola P, Pekonen F, Rutanen EM (1989) Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata. Obstet Gynecol 74:658\u2013662","journal-title":"Obstet Gynecol"},{"key":"728_CR29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1210\/endo.131.4.1396310","volume":"131","author":"KG Nelson","year":"1992","unstructured":"Nelson KG, Takahashi T, Lee DC et al (1992) Transforming growth factor-alpha is a potential mediator of estrogen action in the mouse uterus. Endocrinology 131:1657\u20131664","journal-title":"Endocrinology"},{"key":"728_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/1071-5576(95)94620-A","volume":"2","author":"S Mora","year":"1995","unstructured":"Mora S, Diehl T, Stewart EA (1995) Prolactin is an autocrine growth regulator for human myometrial and leiomyoma cells. J Soc Gynecol Invest 2:396","journal-title":"J Soc Gynecol Invest"},{"key":"728_CR31","first-page":"218","volume-title":"Reproductive endocrinology","author":"J Strauss","year":"1999","unstructured":"Strauss J, Coutifaris C (1999) The endometrium and myometrium: regulation and dysfunction. In: Yen S, Jaffe JM, Barbieri RL (eds) Reproductive endocrinology. Saunders Press, Philadelphia, pp 218\u2013256"},{"key":"728_CR32","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/0002-9378(90)90667-V","volume":"163","author":"AJ Friedman","year":"1990","unstructured":"Friedman AJ, Lobel SM, Rein MS, Barbieri RL (1990) Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis. Am J Obstet Gynecol 163:1114\u20131119","journal-title":"Am J Obstet Gynecol"},{"key":"728_CR33","first-page":"1531","volume":"11","author":"R Kaaks","year":"2002","unstructured":"Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11:1531\u20131543","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"728_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/bjc.1988.44","volume":"57","author":"TJ Key","year":"1988","unstructured":"Key TJ, Pike MC (1988) The dose-effect relationship between \u2018unopposed\u2019 oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 57:205\u2013212","journal-title":"Br J Cancer"},{"key":"728_CR35","first-page":"56","volume":"50","author":"L Rosenberg","year":"1995","unstructured":"Rosenberg L, Adams-Campbell L, Palmer JR (1995) The Black Women\u2019s Health Study: a follow-up study for causes and preventions of illness. J Am Med Womens Assoc 50:56\u201358","journal-title":"J Am Med Womens Assoc"},{"key":"728_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/01.AOG.0000154161.03418.e3","volume":"105","author":"LA Wise","year":"2005","unstructured":"Wise LA, Palmer JR, Stewart EA, Rosenberg L (2005) Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women\u2019s Health Study. Obstet Gynecol 105:563\u2013568","journal-title":"Obstet Gynecol"},{"key":"728_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/00001648-199001000-00013","volume":"1","author":"G Block","year":"1990","unstructured":"Block G, Hartman AM, Naughton D (1990) A reduced dietary questionnaire: development and validation. Epidemiology 1:58\u201364","journal-title":"Epidemiology"},{"key":"728_CR38","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/aje\/kwq293","volume":"172","author":"DA Boggs","year":"2010","unstructured":"Boggs DA, Palmer JR, Wise LA et al (2010) Fruit and vegetable intake in relation to risk of breast cancer in the Black Women\u2019s Health Study. Am J Epidemiol 172:1268\u20131279","journal-title":"Am J Epidemiol"},{"key":"728_CR39","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/01.ede.0000158742.11877.99","volume":"16","author":"LA Wise","year":"2005","unstructured":"Wise LA, Palmer JR, Spiegelman D et al (2005) Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology 16:346\u2013354","journal-title":"Epidemiology"},{"key":"728_CR40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life-tables. J Roy Stat Soc 34:187\u2013220","journal-title":"J Roy Stat Soc"},{"key":"728_CR41","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1214\/aos\/1176345976","volume":"10","author":"PK Andersen","year":"1982","unstructured":"Andersen PK, Gill RD (1982) Cox\u2019s regression model for counting processes: a large sample study. Ann Stat 10:1100\u20131120","journal-title":"Ann Stat"},{"key":"728_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jmig.2013.11.011","volume":"21","author":"J Shwayder","year":"2014","unstructured":"Shwayder J, Sakhel K (2014) Imaging for uterine myomas and adenomyosis. J Minim Invasive Gynecol 21:362\u2013376","journal-title":"J Minim Invasive Gynecol"},{"key":"728_CR43","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496\u2013509","journal-title":"J Am Stat Assoc"},{"key":"728_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10552-014-0510-3","volume":"26","author":"ML Cote","year":"2015","unstructured":"Cote ML, Alhajj T, Ruterbusch JJ et al (2015) Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes Control 26:287\u2013296","journal-title":"Cancer Causes Control"},{"key":"728_CR45","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1158\/1055-9965.EPI-11-0735","volume":"21","author":"SH Olson","year":"2012","unstructured":"Olson SH, Atoria CL, Cote ML et al (2012) The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev 21:753\u2013760","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"728_CR46","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31:2607\u20132618","journal-title":"J Clin Oncol"},{"key":"728_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1302736","volume":"369","author":"M Mehine","year":"2013","unstructured":"Mehine M, Kaasinen E, Makinen N et al (2013) Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med 369:43\u201353","journal-title":"N Engl J Med"},{"key":"728_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.humpath.2012.05.013","volume":"44","author":"L Romero-Perez","year":"2013","unstructured":"Romero-Perez L, Castilla MA, Lopez-Garcia MA et al (2013) Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis. Hum Pathol 44:244\u2013254","journal-title":"Hum Pathol"},{"key":"728_CR49","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","volume":"27","author":"E Bertsch","year":"2014","unstructured":"Bertsch E, Qiang W, Zhang Q et al (2014) MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod Pathol 27:1144\u20131153","journal-title":"Mod Pathol"},{"key":"728_CR50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/1098-2264(200007)28:3<235::AID-GCC1>3.0.CO;2-7","volume":"28","author":"AH Ligon","year":"2000","unstructured":"Ligon AH, Morton CC (2000) Genetics of uterine leiomyomata. Genes Chromosomes Cancer 28:235\u2013245","journal-title":"Genes Chromosomes Cancer"},{"key":"728_CR51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbagrm.2009.11.007","volume":"1799","author":"M Fedele","year":"2010","unstructured":"Fedele M, Fusco A (2010) HMGA and cancer. Biochim Biophys Acta 1799:48\u201354","journal-title":"Biochim Biophys Acta"},{"key":"728_CR52","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1365-2559.2011.04105.x","volume":"60","author":"WG McCluggage","year":"2012","unstructured":"McCluggage WG, Connolly LE, McBride HA, Kalloger S, Gilks CB (2012) HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis. Histopathology 60:547\u2013553","journal-title":"Histopathology"},{"key":"728_CR53","unstructured":"Howlader N, Noone AM, Krapcho M et al (2014) SEER cancer statistics review, 1975\u20132012, National Cancer Institute. Bethesda, MD. http:\/\/seer.cancer.gov\/csr\/1975_2012\/"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-016-0728-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-016-0728-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-016-0728-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-016-0728-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T17:40:33Z","timestamp":1718386833000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-016-0728-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,29]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["728"],"URL":"https:\/\/doi.org\/10.1007\/s10552-016-0728-3","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,29]]},"assertion":[{"value":"15 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}